Skip to content

AptarGroup ATR Quick ratio

Quick ratio at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
0.0×
Amcor logo
AmcorAMCR
1.4×-0.3×
Nordson logo
NordsonNDSN
1.6×0.0×
Baxter International logo
Baxter InternationalBAX
1.2×-0.2×
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
2.7×-5.4×
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
1.4×0.0×

Other financials

Income statement

See full
Revenue$982.9M+10.8%
Gross profit$351.9M+4.6%
Operating income$107.5M-5.2%
Net income$72.7M-7.8%
EPS (diluted)$1.12-4.3%

Balance sheet

See full
Cash & equivalents$225.0M+78.8%
Total debt$1.4B+32.7%
Total equity$2.6B+3.6%
Total assets$5.1B+12.6%

Cash flow

See full
Operating cash flow$118.7M+43.5%
CapEx$65.4M+15.0%
Free cash flow$53.3M+106%

Valuation

See full
Market cap$7.68B-17.9%
Enterprise value$8.89B-13.9%
P/E19.9×-5.4×
P/S-0.6×

Profitability

See full
Gross margin36.7%-1.6pp
Operating margin12.8%-1.2pp
Net margin10%-0.4pp
FCF margin8.4%-2.1pp

Returns & leverage

See full
Return on equity15%-0.2pp
Debt / equity0.5×+0.1×
Current ratio1.7×+0.4×

Where this comes from

Calculated from AptarGroup’s reported figures.

Based on the most recent quarter.

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AptarGroup's quick ratio?
AptarGroup (ATR) reported quick ratio of 1.1× in Q1 2026.
How has AptarGroup's quick ratio changed year-over-year?
AptarGroup's quick ratio increased by 34.5% year-over-year, from 0.9× to 1.1×.
What is the long-term trend for AptarGroup's quick ratio?
Over 5 years (2020 to 2025), AptarGroup's quick ratio has grown at a -1.7% compound annual growth rate (CAGR), from 1.3× to 1.2×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.